Test surge and data sharing multiple award IDIQ
Active Awarded Last action
- Contract number
- 75D30124D20079
- Awardee
-
Ginkgo Bioworks, Inc. UEI ZRHJUJQSBRA4
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 4 $8,255,244 obligated
Award facts
- Combined order value
-
- $8,255,244 Current, with exercised options
- $54,641,589 Potential, with all options
- Last date to order 43% complete
- IDV ceiling 7% used
- $118,000,000.00
- Maximum order
- $500,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention awarded an indefinite-delivery contract to Ginkgo Bioworks, Inc. on September 6, 2024, with a ceiling of $118 million and ultimate completion date of September 5, 2029. This is a multiple-award IDIQ with no set-aside.
Place of performance is Boston, Massachusetts. The contract procures metagenomic next-generation sequencing services, pathogen detection, and test surge capabilities supporting CDC public health monitoring and emergency response initiatives under Executive Order 14398.
The period of performance runs through September 5, 2029. Four delivery orders have been issued under this IDIQ to date: a firm fixed-price order issued September 6, 2024, with ceiling of $50.2 million and completion date September 5, 2029; a time-and-materials order issued January 16, 2025, with ceiling of $449,761.53 and completion date May 15, 2025; a time-and-materials order issued September 27, 2024, with ceiling of $775,180 and completion date September 26, 2025; and a firm fixed-price order issued May 3, 2026, with ceiling of $3.2 million and completion date April 14, 2028. Combined potential value of these four orders is $54.6 million. All orders specify Boston, Massachusetts as place of performance.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Metagenomic next-generation sequencing (mngs) | CDC Pittsburgh | $3,199,875 | |
| Test surge and data sharing multiple award IDIQ | CDC Pittsburgh | $449,762 | |
| Test surge and data sharing multiple award IDIQ | CDC Pittsburgh | $775,180 | |
| Test surge and data sharing multiple award IDIQ | CDC Pittsburgh | $3,830,427 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75D30124D20079?
75D30124D20079 was awarded to Ginkgo Bioworks, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 6, 2024.
How much is contract 75D30124D20079 worth?
Orders under 75D30124D20079 have obligated $8,255,244. Their combined potential value, with all options, is $54,641,589. 75D30124D20079's own ceiling is $118,000,000. A single order can be worth up to $500,000.
How many orders have been placed under contract 75D30124D20079?
4 orders have been placed under 75D30124D20079, the latest on May 3, 2026.
Who can order from contract 75D30124D20079?
75D30124D20079 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75D30124D20079 part of a contract vehicle?
Yes. 75D30124D20079 is part of Test Surge and Data Sharing.
Was contract 75D30124D20079 competed?
The extent of competition for 75D30124D20079 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV